Collectively, these results demonstrated a progressively lower gradient of Y101 frequencies associated with FCRL6 expression and tissue of origin compared to B-1a and CLL cells (Supplementary Figure 6E). This evidence concerns the gene FCRL6 and B-cell chronic lymphocytic leukemia.